Alex Pharma reports 19% YoY profit hike in 5 months in Egypt

Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) posted a 19% year-on-year (YoY) in net profit after tax from July 1st until November 30th, according to financial statements filed to the Egyptian Exchange (EGX) on Tuesday.

The company’s net profit after tax jumped to EGP 71.283 million in July-November from EGP 59.908 million the year before.

Operating revenue reached EGP 628.245 million in the period that ended on November 30th, up from EGP 475.949 million a year earlier.

Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.